1.
Papadakis K, Portelli F, Schultz K, Olsson Sterky H, Vassilaki I, Lapins J, et al. POT1 genetic testing in melanoma-prone families in Sweden: germline variant prevalence and tumor spectrum in identified carriers. AO [Internet]. 2025 Aug. 25 [cited 2026 May 27];64:1102-8. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/44048